인간 융모성 성선자극호르몬 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 연평균 8.4%의 CAGR로 14억 2,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 불임 발생률 증가, 다낭성난소증후군의 급증, 여성 불임 증가, 동물 의학에서 HCG 사용량 증가에 기인합니다. 예측 기간 동안 주요 동향으로는 임신 감지 기술의 발전, 혁신적인 약물 처방, 기술 통합, 연구개발에 대한 집중, 제품 혁신 등이 있습니다.
불임의 증가율은 향후 몇 년 동안 인간 융모성 성선자극호르몬(hCG) 시장의 성장을 촉진할 것으로 예상됩니다. 불임은 최소 1년 이상 피임 없이 성관계를 지속해도 임신을 할 수 없는 상태로 정의되며, 증가 추세에 있습니다. 그 요인으로는 출산 지연, 생활습관 변화, 환경 노출, 병적 상태 등을 들 수 있습니다. 인간 융모성 성선자극호르몬(hCG)은 불임 치료에서 여성의 배란을 자극하고, 남성의 테스토스테론 생산을 지원하며, 난자 방출을 촉진하고 불임 치료 결과를 개선하기 위해 활용되고 있습니다. 예를 들어, 2023년 4월 세계보건기구(WHO)는 불임이 성인 인구의 약 17.5%, 즉 전 세계 약 6명 중 1명꼴로 발병하고 있다고 보고하며, 접근성이 높고 질 높은 불임 치료가 시급히 필요하다고 강조했습니다. 그 결과, 불임율의 증가가 인간 융모성 성선자극호르몬 시장의 성장을 견인하고 있습니다.
인간 융모성 성선자극호르몬 시장의 주요 기업들은 진단 정확도 향상, 환자 결과 개선, 시장 확대를 위해 임신 감지 키트와 같은 혁신적인 제품 개발에 주력하고 있습니다. 임신 감지 키트는 체내의 인간 융모성 성선자극호르몬(hCG)을 감지하여 임신을 확인하도록 설계되어 있습니다. 예를 들어, 미국의 의료기기 제조업체인 Proov는 2022년 6월에 조기 임신을 감지할 수 있는 새로운 hCG 검사약을 출시하여 여성이 생리 예정일 6일 전에 임신을 확인할 수 있도록 했습니다. 이 검사는 소변 내 hCG를 99% 이상의 신뢰도로 확인하여 여성이 기존 검사보다 더 빨리 임신 상태를 모니터링하고 정보에 입각한 생식 관련 건강 결정을 내릴 수 있는 신뢰할 수 있는 친숙한 방법을 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 인간 융모성 성선자극호르몬 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 인간 융모성 성선자극호르몬 시장 : 성장률 분석
- 세계의 인간 융모성 성선자극호르몬 시장 실적 : 규모와 성장, 2019-2024
- 세계의 인간 융모성 성선자극호르몬 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 인간 융모성 성선자극호르몬 전체 시장(TAM)
제6장 시장 세분화
- 세계의 인간 융모성 성선자극호르몬 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 천연자원 추출
- 재조합 기술
- 세계의 인간 융모성 성선자극호르몬 시장 : 치료 분야별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 여성 불임 치료
- 정자감소증 치료
- 남성 성선기능저하증
- 기타 치료 분야
- 세계의 인간 융모성 성선자극호르몬 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 소매 약국
- 온라인 약국
- 세계의 인간 융모성 성선자극호르몬 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 불임 치료 클리닉
- 조사기관
- 기타 최종사용자
- 세계의 인간 융모성 성선자극호르몬 시장, 천연자원 추출 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 임산부 뇨에서 추출
- 동물 유래 추출
- 세계의 인간 융모성 성선자극호르몬 시장, 재조합 기술 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 재조합 HCG
- 치료용 재조합 HCG
- 진단 용도용 재조합 HCG
제7장 지역별·국가별 분석
- 세계의 인간 융모성 성선자극호르몬 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 인간 융모성 성선자극호르몬 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 인간 융모성 성선자극호르몬 시장 : 경쟁 구도
- 인간 융모성 성선자극호르몬 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
- Janssen Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
- Sandoz International GmbH
- Sun Pharmaceutical Industries Limited
- Menarini Group
- Cipla Limited
- Hikma Pharmaceuticals plc
- Ferring Pharmaceuticals Inc.
- Intas Pharmaceuticals Ltd.
- Zydus Lifesciences Limited
- Lupin Limited
- Shenzhen Hepalink Pharmaceutical Group Co. Ltd.
- Scripps Laboratories Inc.
- Aspen Pharmacare Holdings Limited
- Corona Remedies Pvt Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 인간 융모성 성선자극호르몬 시장 2029 : 새로운 기회를 제공하는 국가
- 인간 융모성 성선자극호르몬 시장 2029 : 새로운 기회를 제공하는 부문
- 인간 융모성 성선자극호르몬 시장 2029 : 성장 전략
제36장 부록
ksm
Human chorionic gonadotropin (hCG) is a hormone produced during pregnancy by the placenta shortly after embryo implantation in the uterus. It is essential for sustaining pregnancy by stimulating the corpus luteum in the ovary to produce progesterone, which maintains the uterine lining and prevents its breakdown.
The primary technologies for producing hCG are natural source extraction and recombinant technology. Recombinant technology involves combining DNA fragments from various organisms to create new genetic combinations. hCG is used in treating female infertility, oligospermia, male hypogonadism, and other conditions. It is distributed through hospital pharmacies, retail pharmacies, and online pharmacies, and is utilized by fertility clinics, research institutions, and other users.
The human chorionic gonadotropin market research report is one of a series of new reports from The Business Research Company that provides human chorionic gonadotropin market statistics, including human chorionic gonadotropin industry global market size, regional shares, competitors with a human chorionic gonadotropin market share, detailed human chorionic gonadotropin market segments, market trends, and opportunities, and any further data you may need to thrive in the human chorionic gonadotropin industry. This human chorionic gonadotropin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The human chorionic gonadotropin market size has grown strongly in recent years. It will grow from $0.95 billion in 2024 to $1.03 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to the rise in the prevalence of hypogonadism in the geriatric population, increase in awareness toward HCG among healthcare professionals and patients, rise in popularity of fertility tourism, increase in the geriatric population, and increase in affordability and improvement in healthcare facilities.
The human chorionic gonadotropin market size is expected to see strong growth in the next few years. It will grow to $1.42 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to the increasing incidence of infertility, surging prevalence of polycystic ovary syndrome, increasing female infertility, and rising usage of HCG in veterinary medicine. Major trends in the forecast period include advancements in pregnancy detection, innovative drug formulations, technological integration, focus on research and development, and product innovation.
An increasing rate of infertility is anticipated to propel the growth of the human chorionic gonadotropin (hCG) market in the coming years. Infertility, defined as the inability to conceive after at least one year of consistent, unprotected intercourse, is on the rise. Contributing factors include delayed childbearing, lifestyle changes, environmental exposures, and medical conditions. Human chorionic gonadotropin (hCG) is utilized in infertility treatments to stimulate ovulation in women and support testosterone production in men, facilitating egg release and improving fertility outcomes. For instance, in April 2023, the World Health Organization reported that infertility affects approximately 17.5% of the adult population, or roughly one in six people globally, underscoring the urgent need for accessible, high-quality fertility care. Consequently, the rising infertility rate is driving the growth of the human chorionic gonadotropin market.
Key players in the human chorionic gonadotropin market are focusing on the development of innovative products, such as pregnancy detection kits, to enhance diagnostic accuracy, improve patient outcomes, and broaden market reach. Pregnancy detection kits are designed to confirm pregnancy by detecting human chorionic gonadotropin (hCG) in the body. For example, in June 2022, Proov, a US-based medical equipment manufacturer, introduced new hCG tests for early pregnancy detection, enabling women to verify pregnancy up to six days before their expected period. These tests identify hCG in urine with a reliability rate exceeding 99%, providing a dependable and accessible method for women to monitor their pregnancy status earlier than traditional tests and make informed reproductive health decisions.
In September 2023, Lupin Limited, an India-based pharmaceutical company, acquired five brands from Menarini for an undisclosed sum. This acquisition aims to expand Lupin's portfolio and strengthen its position in key therapeutic areas by integrating five established brands from Menarini. Menarini Group, an Italy-based pharmaceutical and diagnostics company, offers services related to human chorionic gonadotropin (hCG).
Major companies operating in the human chorionic gonadotropin market are Pfizer Inc., Merck & Co Inc., Novartis AG, Bristol-Myers Squibb Company, Fresenius Kabi AG, Janssen Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Limited, Menarini Group, Cipla Limited, Hikma Pharmaceuticals plc, Ferring Pharmaceuticals Inc., Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Lupin Limited, Shenzhen Hepalink Pharmaceutical Group Co. Ltd., Scripps Laboratories Inc., Aspen Pharmacare Holdings Limited, Corona Remedies Pvt Ltd., Sanzyme Private Limited, Biocare Medical LLC, Lee BioSolutions Inc., MyBioSource Inc.
North America was the largest region in the human chorionic gonadotropin market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the human chorionic gonadotropin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The human chorionic gonadotropin market includes revenues earned by entities by providing services such as fertility treatments, hormone level monitoring, assisted reproductive technologies (ART), and pregnancy testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Human Chorionic Gonadotropin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on human chorionic gonadotropin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for human chorionic gonadotropin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human chorionic gonadotropin market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Technology: Natural Source Extraction; Recombinant Technology
- 2) By Therapeutic Area: Female Infertility Treatment; Oligospermic Treatment; Male Hypogonadism; Other Therapeutic Areas
- 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
- 4) By End User: Fertility Clinics; Research Institutions; Other End Users
- Subsegments:
- 1) By Natural Source Extraction: Extraction From Pregnant Women's Urine; Extraction From Animal Sources
- 2) By Recombinant Technology: Recombinant Hcg; Recombinant Hcg For Therapeutic Use; Recombinant Hcg For Diagnostic Applications
- Companies Mentioned: Pfizer Inc.; Merck & Co Inc.; Novartis AG; Bristol-Myers Squibb Company; Fresenius Kabi AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Human Chorionic Gonadotropin Market Characteristics
3. Human Chorionic Gonadotropin Market Trends And Strategies
4. Human Chorionic Gonadotropin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Human Chorionic Gonadotropin Growth Analysis And Strategic Analysis Framework
- 5.1. Global Human Chorionic Gonadotropin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Human Chorionic Gonadotropin Market Growth Rate Analysis
- 5.4. Global Human Chorionic Gonadotropin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Human Chorionic Gonadotropin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Human Chorionic Gonadotropin Total Addressable Market (TAM)
6. Human Chorionic Gonadotropin Market Segmentation
- 6.1. Global Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Natural Source Extraction
- Recombinant Technology
- 6.2. Global Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Female Infertility Treatment
- Oligospermic Treatment
- Male Hypogonadism
- Other Therapeutic Areas
- 6.3. Global Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 6.4. Global Human Chorionic Gonadotropin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Fertility Clinics
- Research Institutions
- Other End Users
- 6.5. Global Human Chorionic Gonadotropin Market, Sub-Segmentation Of Natural Source Extraction, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Extraction From Pregnant Women's Urine
- Extraction From Animal Sources
- 6.6. Global Human Chorionic Gonadotropin Market, Sub-Segmentation Of Recombinant Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Recombinant Hcg
- Recombinant Hcg For Therapeutic Use
- Recombinant Hcg For Diagnostic Applications
7. Human Chorionic Gonadotropin Market Regional And Country Analysis
- 7.1. Global Human Chorionic Gonadotropin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Human Chorionic Gonadotropin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Human Chorionic Gonadotropin Market
- 8.1. Asia-Pacific Human Chorionic Gonadotropin Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Human Chorionic Gonadotropin Market
- 9.1. China Human Chorionic Gonadotropin Market Overview
- 9.2. China Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Human Chorionic Gonadotropin Market
- 10.1. India Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Human Chorionic Gonadotropin Market
- 11.1. Japan Human Chorionic Gonadotropin Market Overview
- 11.2. Japan Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Human Chorionic Gonadotropin Market
- 12.1. Australia Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Human Chorionic Gonadotropin Market
- 13.1. Indonesia Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Human Chorionic Gonadotropin Market
- 14.1. South Korea Human Chorionic Gonadotropin Market Overview
- 14.2. South Korea Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Human Chorionic Gonadotropin Market
- 15.1. Western Europe Human Chorionic Gonadotropin Market Overview
- 15.2. Western Europe Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Human Chorionic Gonadotropin Market
- 16.1. UK Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Human Chorionic Gonadotropin Market
- 17.1. Germany Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Human Chorionic Gonadotropin Market
- 18.1. France Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Human Chorionic Gonadotropin Market
- 19.1. Italy Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Human Chorionic Gonadotropin Market
- 20.1. Spain Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Human Chorionic Gonadotropin Market
- 21.1. Eastern Europe Human Chorionic Gonadotropin Market Overview
- 21.2. Eastern Europe Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Human Chorionic Gonadotropin Market
- 22.1. Russia Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Human Chorionic Gonadotropin Market
- 23.1. North America Human Chorionic Gonadotropin Market Overview
- 23.2. North America Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Human Chorionic Gonadotropin Market
- 24.1. USA Human Chorionic Gonadotropin Market Overview
- 24.2. USA Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Human Chorionic Gonadotropin Market
- 25.1. Canada Human Chorionic Gonadotropin Market Overview
- 25.2. Canada Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Human Chorionic Gonadotropin Market
- 26.1. South America Human Chorionic Gonadotropin Market Overview
- 26.2. South America Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Human Chorionic Gonadotropin Market
- 27.1. Brazil Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Human Chorionic Gonadotropin Market
- 28.1. Middle East Human Chorionic Gonadotropin Market Overview
- 28.2. Middle East Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Human Chorionic Gonadotropin Market
- 29.1. Africa Human Chorionic Gonadotropin Market Overview
- 29.2. Africa Human Chorionic Gonadotropin Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Human Chorionic Gonadotropin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Human Chorionic Gonadotropin Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Human Chorionic Gonadotropin Market Competitive Landscape And Company Profiles
- 30.1. Human Chorionic Gonadotropin Market Competitive Landscape
- 30.2. Human Chorionic Gonadotropin Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
31. Human Chorionic Gonadotropin Market Other Major And Innovative Companies
- 31.1. Janssen Pharmaceuticals Inc.
- 31.2. Teva Pharmaceutical Industries Ltd.
- 31.3. Sandoz International GmbH
- 31.4. Sun Pharmaceutical Industries Limited
- 31.5. Menarini Group
- 31.6. Cipla Limited
- 31.7. Hikma Pharmaceuticals plc
- 31.8. Ferring Pharmaceuticals Inc.
- 31.9. Intas Pharmaceuticals Ltd.
- 31.10. Zydus Lifesciences Limited
- 31.11. Lupin Limited
- 31.12. Shenzhen Hepalink Pharmaceutical Group Co. Ltd.
- 31.13. Scripps Laboratories Inc.
- 31.14. Aspen Pharmacare Holdings Limited
- 31.15. Corona Remedies Pvt Ltd.
32. Global Human Chorionic Gonadotropin Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Human Chorionic Gonadotropin Market
34. Recent Developments In The Human Chorionic Gonadotropin Market
35. Human Chorionic Gonadotropin Market High Potential Countries, Segments and Strategies
- 35.1 Human Chorionic Gonadotropin Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Human Chorionic Gonadotropin Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Human Chorionic Gonadotropin Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
